ArticleEpilepsia2026
Pentanucleotide repeat instability and transmission in benign adult familial myoclonic epilepsy types 1, 4, and 8.
Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveBenign adult familial myoclonic epilepsy (BAFME) is a rare autosomal dominant disorder characterized by tremor and myoclonic seizures. To date, seven genetic subtypes have been identified, all caused by noncoding pentanucleotide repeat expansions-typically TTTTA expansions with additional TTTCA insertions-across distinct loci. Although aberrant repeat expansions are a shared hallmark, it remains unclear whether different BAFME subtypes exhibit similar patterns of repeat length variability and inheritance. We aimed to characterize pentanucleotide repeat structure, repeat length variability across reads, and intergenerational transmission patterns across multiple BAFME subtypes, and to determine whether these mutational dynamics differ among BAFME1, BAFME4, and BAFME8.
methodsWe performed whole-genome long-read sequencing and targeted adaptive sampling long-read sequencing on 18 affected individuals from three multigenerational families with BAFME1 (SAMD12), BAFME4 (YEATS2), and BAFME8 (RAI1). Repeat structure, repeat length variability across reads, and intergenerational transmission dynamics were analyzed.
resultsAcross patients, 7-33 long reads containing expanded repeats were identified. Several differences in repeat length distributions across reads were observed among the families studied. The BAFME1 family showed comparatively narrower distributions, whereas broader variability was observed in the BAFME4 and BAFME8 families. In BAFME1 and BAFME8, TTTCA repeat length showed a positive correlation with age, consistent with age-associated increases in repeat length variability across reads. Parent-to-offspring transmissions were often associated with increases in repeat length, most prominently in BAFME8. Sibling comparisons further indicated higher variability in TTTCA than in TTTTA repeats. SIGNIFICANCE: Our study demonstrates distinct patterns of repeat length variability and inheritance across the families analyzed. These findings suggest that the genomic context of pentanucleotide expansions may influence repeat behavior and could contribute to phenotypic variability in BAFME.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.